The management of blood pressure after stroke

Neurologist

Volumn 13, Issue 4, 2007, Pages 171-181

  Wityk, Robert J ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Blood pressure; Cerebral blood flow; Intracerebral hemorrhage; Prevention; Stroke

Indexed keywords

CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; FLUDROCORTISONE; INDAPAMIDE; LABETALOL; MIDODRINE; NICARDIPINE; NORADRENALIN; PERINDOPRIL; PHENYLEPHRINE; RAMIPRIL; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIFFUSION WEIGHTED IMAGING; DRUG WITHDRAWAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MEAN ARTERIAL PRESSURE; MONOTHERAPY; NEUROLOGIC EXAMINATION; NONHUMAN; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TRANSIENT ISCHEMIC ATTACK;

BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; HUMANS; RECURRENCE;

EID: 34447341493     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318068b63e     Document Type: Review

References (97)

1. Gorelick PB. Stroke prevention. Arch Neurol. 1995;52:347-355.
2. Wolf PA, D'Agostino RB. Epidemiology of stroke. In: Barnett HJM, Mohr JP, Stein BM, et al, eds. Stroke: Pathophysiology, Diagnosis, and Management. 3rd ed. New York: Churchill Livingstone; 1998.
3. Caplan LR. Binswanger's disease: revisited. Neurology. 1995;45:626-633.
4. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997;16:149-162.
5. Perry HM Jr, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000;284:465-471.
6. Rigaud AS, Seux ML, Staessen JA, et al. Cerebral complications of hypertension. J Hum Hypertens. 2000;14:605-616.
7. Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139-1144.
8. Staessen JA, Fagard R, Thijs L, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
9. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases: American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
10. Irie K, Yamaguchi T, Minematsu K, et al. The J-curve phenomenon in stroke recurrence. Stroke. 1993;24:1844-1849.
11. Mori S, Sadoshima S, Fujii K, et al. Decrease in cerebral blood flow with blood pressure reductions in patients with chronic stroke. Stroke. 1993;24:1376-1381.
12. Bath FJ, Bath PMW. What is the correct management of blood pressure in acute stroke? the Blood Pressure in Acute Stroke Collaboration. Cerebrovasc Dis. 1997;7:205-213.
13. Caplan LR. Worsening in ischemic stroke patients: is it time for a new strategy? Stroke. 2002;33:1443-1445.
14. Sacco RL, Shi T, Zamanillo MC, et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.
15. Jorgensen HS, Nakayama H, Reith J, et al. Stroke recurrence: predictors, severity, and prognosis: the Copenhagen Stroke Study. Neurology. 1997;48:891-895.
16. Arakawa S, Saku Y, Ibayashi S, et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke. 1998;29:1806-1809.
17. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin- convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
18. Bosch J, Yusuf S, Pogue J, et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002;324:699-702.
19. Sica DA. The Heart Outcomes Prevention Evaluation Study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ? Opin Nephrol Hypertens. 2001;10:587-601.
20. PROGRESS Collaborative Group. Randomized trial of a perinoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
21. van Gijn J. The PROGRESS Trial: preventing strokes by lowering blood pressure in patients with cerebral ischemia: emerging therapies: critique of an important advance. Stroke. 2002;33:319-320.
22. Staessen JA, Wang J. Blood pressure lowering for the secondary prevention of stroke. Lancet. 2001;358:1026-1027.
23. Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 1981;246:2177-2180.
24. Morfis L, Schwartz RS, Poulos R, et al. Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke. 1997;28:1401-1405.
25. Christensen H, Meden P, Overgaard K, et al. The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand. 2002;106:142-147.
26. Jorgensen HS, Nakayama H, Christensen HR, et al. Blood pressure in acute stroke: the Copenhagen Stroke Study. Cerebrovasc Dis. 2002;13:204-209.
27. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin. 1992;10:167-176.
28. Broderick J, Brott T, Barsan W, et al. Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med. 1993;22:1438-1443.
29. Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke. 1993;24:1372-1375.
30. Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33:1315-1320.
31. Demchuk AM, Tanne D, Hill MD, et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology. 2001;57:474-480.
32. Jorgensen HS, Nakayama H, Raaschou HO, et al. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156-159.
33. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology. 1993;43:461-467.
34. Spence JD, Del Maestro RF. Hypertension in acute ischemic strokes. Treat. Arch Neurol. 1985;42:1000-1002.
35. Yatsu FM, Zivin J. Hypertension in acute ischemic strokes: not to treat. Arch Neurol. 1985;42:999-1000.
36. Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke (Cochrane Review). Cochrane Library. Issue 4;2002 ed. Oxford: Update Software; 2002.
37. Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? a randomized controlled trial using single photon emission computed tomography. Arch Neurol. 1993;50:855-862.
38. Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:507-510.
39. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke. 1998;29:1504-1509.
40. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723-725.
41. Hakim AM. Ischemic penumbra: the therapeutic window. Neurology. 1998;51:S44-46.
42. Graham DI. Ischaemic brain damage of cerebral perfusion failure after treatment of severe hypertension. BMJ. 1975;4:739.
43. Lavin P. Management of hypertension in patients with acute stroke. Arch Intern Med. 1986;146:66-68.
44. Fischberg GM, Lozano E, Rajamani K, et al. Stroke precipitated by moderate blood pressure reduction. J Emerg Med. 2000;19:339-346.
45. Kanji S, Corman C, Douen AG. Blood pressure management in acute stroke: comparison of current guidelines with prescribing patterns. Can J Neurol Sci. 2002;29:125-131.
46. Levy DE, Brott TG, Haley EC Jr, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994;25:291-297.
47. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
48. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
49. Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation. 2002;105:1679-1685.
50. Gilligan AK, Markus R, Read S, et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke. 2002;33:2236-2242.
51. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol. 2001;58:2009-2013.
52. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke. 2002;33:2047-2052.
53. Larrue V, von Kummer R, del Zoppo G, et al. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960.
54. Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32:438-441.
55. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1996;27:1711-1718.
56. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-1460.
57. Fogelholm R, Avikainen S, Morrow K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke. 1997;28:1396-1400.
58. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
59. Qureshi AI, Wilson DA, Hanley DF, et al. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999;52:266-272.
60. Qureshi AI, Wilson DA, Hanley DF, et al. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med. 1999;27:965-971.
61. Powers WJ, Adams RE, Yundt KD, et al. Acute pharmacologic hypotension after intracerebral hemorrhage does not change cerebral blood flow [abstract]. Stroke. 1991;130:242.
62. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804-810.
63. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18-24.
64. Broderick JP, Adams HP Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905-915.
65. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
66. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
67. + at critical levels of brain ischemia. Stroke. 1977;8:51-57.
68. Olsen TS, Bruhn P, Oberg RGE. Cortical hypoperfusion as a possible cause of "subcortical aphasia." Brain. 1986;109:393-410.
69. Olsen TS, Larsen B, Herning M, et al. Blood flow and vascular reactivity in collaterally perfused brain tissue: evidence of an ischemic penumbra in patients with acute stroke. Stroke. 1983;14:332-341.
70. Baron JC, Marchal G. Functional imaging in vascular disorders. In: Mazziotta JC, Toga AW, Frackowiak RSJ, eds. Brain Mapping: The Disorders. San Diego: Academic Press; 2000:299-316.
71. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000;20:1276-1293.
72. Powers WJ, Grubb RL, Darriet D, et al. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600-608.
73. Kaufmann AM, Firlik AD, Fukui MB, et al. Ischemic core and penumbra in human stroke. Stroke. 1999;30:93-99.
74. Derdeyn CP, Yundt KD, Videen TO, et al. Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. Stroke. 1998;29:754-758.
75. Baron JC, Bousser MG, Rey A, et al. Reversal of focal "miseryperfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia: a case study with 15O positron tomography. Stroke. 1981;12:454-459.
76. Hayashi S, Nehls DG, Kieck CF, et al. Beneficial effects of induced hypertension on experimental stroke in awake monkeys. J Neurosurg. 1984;60:151-157.
77. Cole DJ, Matsumura JS, Drummond JC, et al. Focal cerebral ischemia in rats: effects of induced hypertension, during reperfusion, on CBF. J Cereb Blood Flow Metab. 1992;12:64-69.
78. Drummond JC, Oh Y, Cole DJ, et al. Phenylephrine induced hypertension reduces ischemia following middle cerebral artery occlusion in rats. Stroke. 1989;20:1538-1544.
79. Shanbrom E, Levy L. The role of systemic blood pressure in cerebral circulation in carotid and basilar artery thromboses. Am J Med. 1957;23:197-204.
80. Farhat SM, Schneider RC. Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency. J Neurosurg. 1967;27:441-445.
81. Wise G, Sutter R, Burkholder J. The treatment of brain ischemia with vasopressor drugs. Stroke. 1972;3:135-140.
82. Matakas F, Waechter RV, Eibs G. Relation between cerebral perfusion pressure and arterial pressure in brain oedema. Lancet. 1972;1:684.
83. Kassell NF, Peerless SJ, Durward QJ, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11:337-343.
84. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315-2328.
85. Miller JA, Dacey RG, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke. 1995;26:2260-2266.
86. Rordorf G, Cramer SC, Efird JT, et al. Pharmacological elevation of blood pressure in acute stroke: clinical effects and safety. Stroke. 1997;28:2133-2138.
87. Rordorf G, Koroshetz WJ, Ezzeddine MA, et al. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology. 2001;56:1210-1213.
88. Beauchamp NJ, Bryan RN. Acute cerebral ischemic infarction: a pathophysiologic review and radiologic perspective. AJR Am J Roentgenol. 1998;171:73-84.
89. Moseley M, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990;14:330-346.
90. Warach S, Chien D, Li W, et al. Fast magnetic resonance diffusionweighted imaging of acute human stroke. Neurology. 1992;42:1717-1723.
91. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11:423-429.
92. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab. 1998;18:583-609.
93. Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology. 1996;199:391-401.
94. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology. 1998;51:418-426.
95. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology. 1999;52:1750-1756.
96. Hillis AE, Barker PB, Beauchamp NJ, et al. Restoring blood pressure reperfused Wernicke's area and improved language. Neurology. 2001;56:670-672.
97. Hillis AE, Ulatowski JA, Barker PB, et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis. 2003;16:236-246.